NEW YORK STATE COMMON RETIREMENT FUND - LA JOLLA PHARMACEUTICAL CO ownership

LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 56 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q3 2021. The put-call ratio across all filers is 0.62 and the average weighting 1.9%.

Quarter-by-quarter ownership
NEW YORK STATE COMMON RETIREMENT FUND ownership history of LA JOLLA PHARMACEUTICAL CO
ValueSharesWeighting
Q2 2021$1,000
-97.6%
156
-98.4%
0.00%
Q1 2021$42,000
+7.7%
10,0000.0%0.00%
Q4 2020$39,000
-2.5%
10,0000.0%0.00%
Q3 2020$40,000
-7.0%
10,0000.0%0.00%
Q2 2020$43,000
+2.4%
10,0000.0%0.00%
Q1 2020$42,000
+7.7%
10,0000.0%0.00%
Q4 2019$39,000
-79.9%
10,000
-54.5%
0.00%
Q3 2019$194,000
+83.0%
22,000
+91.3%
0.00%
Q2 2019$106,000
-31.2%
11,500
-52.1%
0.00%
Q1 2019$154,000
-31.9%
24,0000.0%0.00%
Q4 2018$226,000
-53.2%
24,0000.0%0.00%
-100.0%
Q3 2018$483,000
-31.0%
24,0000.0%0.00%0.0%
Q2 2018$700,000
+13.6%
24,000
+15.9%
0.00%0.0%
Q1 2018$616,000
-7.5%
20,7000.0%0.00%0.0%
Q4 2017$666,000
+4.7%
20,700
+13.1%
0.00%0.0%
Q3 2017$636,000
+16.7%
18,3000.0%0.00%0.0%
Q2 2017$545,000
+20.8%
18,300
+21.2%
0.00%0.0%
Q1 2017$451,000
+89.5%
15,101
+11.0%
0.00%
Q4 2016$238,000
-26.5%
13,6000.0%0.00%
Q3 2016$324,000
+48.6%
13,6000.0%0.00%
Q2 2016$218,000
-23.2%
13,6000.0%0.00%
Q1 2016$284,000
-22.6%
13,6000.0%0.00%
-100.0%
Q4 2015$367,000
+14.7%
13,600
+18.3%
0.00%0.0%
Q3 2015$320,000
+114.8%
11,500
+89.2%
0.00%
Q2 2015$149,0006,0780.00%
Other shareholders
LA JOLLA PHARMACEUTICAL CO shareholders Q3 2021
NameSharesValueWeighting ↓
TANG KEVIN C 240,000$1,027,00095.09%
TANG CAPITAL MANAGEMENT LLC 10,049,224$43,011,0008.56%
RTW INVESTMENTS, LP 2,327,903$9,963,0000.15%
Boxer Capital, LLC 890,700$3,812,0000.13%
Tibra Equities Europe Ltd 72,600$311,0000.10%
WealthTrust Axiom LLC 25,400$108,0000.04%
GSA CAPITAL PARTNERS LLP 52,749$226,0000.02%
FIRST MIDWEST BANK TRUST DIVISION 34,231$147,0000.02%
HOLLENCREST CAPITAL MANAGEMENT 42,355$181,0000.02%
Summit Global Investments 48,500$208,0000.01%
View complete list of LA JOLLA PHARMACEUTICAL CO shareholders